PL1896034T3 - Mikronizowane kompozycje tanaprogetu i sposoby ich wytwarzania - Google Patents
Mikronizowane kompozycje tanaprogetu i sposoby ich wytwarzaniaInfo
- Publication number
- PL1896034T3 PL1896034T3 PL06751506T PL06751506T PL1896034T3 PL 1896034 T3 PL1896034 T3 PL 1896034T3 PL 06751506 T PL06751506 T PL 06751506T PL 06751506 T PL06751506 T PL 06751506T PL 1896034 T3 PL1896034 T3 PL 1896034T3
- Authority
- PL
- Poland
- Prior art keywords
- preparing
- methods
- same
- micronized tanaproget
- tanaproget compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- PYVFWTPEBMRKSR-UHFFFAOYSA-N tanaproget Chemical compound CN1C(C#N)=CC=C1C1=CC=C(NC(=S)OC2(C)C)C2=C1 PYVFWTPEBMRKSR-UHFFFAOYSA-N 0.000 title 1
- 229950001471 tanaproget Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67555005P | 2005-04-28 | 2005-04-28 | |
| EP06751506A EP1896034B8 (en) | 2005-04-28 | 2006-04-26 | Micronized tanaproget compositions and methods of preparing the same |
| PCT/US2006/015837 WO2006116514A2 (en) | 2005-04-28 | 2006-04-26 | Micronized tanaproget, compositions, and methods of preparing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1896034T3 true PL1896034T3 (pl) | 2010-07-30 |
Family
ID=37023145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06751506T PL1896034T3 (pl) | 2005-04-28 | 2006-04-26 | Mikronizowane kompozycje tanaprogetu i sposoby ich wytwarzania |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US7767668B2 (pl) |
| EP (1) | EP1896034B8 (pl) |
| JP (2) | JP5149159B2 (pl) |
| CN (1) | CN101166532B (pl) |
| AR (1) | AR056328A1 (pl) |
| AT (1) | ATE460937T1 (pl) |
| AU (1) | AU2006241113B2 (pl) |
| BR (1) | BRPI0610437A2 (pl) |
| CA (1) | CA2603806C (pl) |
| CY (1) | CY1110009T1 (pl) |
| DE (1) | DE602006012972D1 (pl) |
| DK (1) | DK1896034T3 (pl) |
| ES (1) | ES2340610T3 (pl) |
| MX (1) | MX2007013465A (pl) |
| PL (1) | PL1896034T3 (pl) |
| PT (1) | PT1896034E (pl) |
| SI (1) | SI1896034T1 (pl) |
| TW (1) | TW200716129A (pl) |
| WO (1) | WO2006116514A2 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200706804B (en) | 2005-02-03 | 2008-10-29 | Gen Hospital Corp | Method for treating gefitinib resistant cancer |
| US20060246128A1 (en) * | 2005-04-28 | 2006-11-02 | Wyeth | Micronized tanaproget and compositions containing same |
| MX2007013469A (es) * | 2005-04-28 | 2008-01-22 | Wyeth Corp | Forma ii polimorfa de tanaproget. |
| AR056328A1 (es) * | 2005-04-28 | 2007-10-03 | Wyeth Corp | TANAPROGET MICRONIZADO, COMPOSICIONES Y MÉTODOS PARA SU PREPARACIoN |
| DE602006007453D1 (de) | 2005-04-28 | 2009-08-06 | Wyeth Corp | Zusammensetzungen mit mikronisiertem tanaproget |
| CN103989687A (zh) | 2005-06-09 | 2014-08-20 | 惠氏公司 | 含有炔雌醇的tanaproget组合物 |
| KR101354828B1 (ko) | 2005-11-04 | 2014-02-18 | 와이어쓰 엘엘씨 | mTOR 저해자, 헤르셉틴, 및/또는 HKI-272의항신생물성 조합 |
| US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| US9040825B2 (en) * | 2007-11-13 | 2015-05-26 | Southwire Company, Llc | Conductors and metal-covered cable with coded information and method of applying coded information |
| EA201070715A1 (ru) | 2007-12-20 | 2011-02-28 | Тева Вимен'С Хелс, Инк. | Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции |
| CA2725598C (en) | 2008-06-17 | 2013-10-08 | Wyeth Llc | Antineoplastic combinations containing hki-272 and vinorelbine |
| MX2011001318A (es) | 2008-08-04 | 2011-03-04 | Wyeth Llc | Combinaciones antineoplasicas de 4-anilino-3-cianoquinolinas y capecitabina. |
| EP2416774B1 (en) | 2009-04-06 | 2015-11-04 | Wyeth LLC | Treatment regimen utilizing neratinib for breast cancer |
| NZ599763A (en) * | 2009-11-09 | 2014-06-27 | Wyeth Llc | Tablet formulations of neratinib maleate |
| EP2498751B1 (en) | 2009-11-09 | 2019-04-03 | Wyeth LLC | Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
| EP2512455B8 (en) | 2009-12-18 | 2014-07-23 | FrieslandCampina Nederland Holding B.V. | Co-processed tablet excipient composition its preparation and use |
| US9326997B2 (en) | 2012-09-24 | 2016-05-03 | Ahlam E. Elakkad | Composition and method for treation Oligoovulation, Oligomenorrhea and Amenorrhea |
| AU2014268779A1 (en) | 2013-05-21 | 2016-01-21 | Predictive Therapeutics, LLC | Therapeutic and method of use |
| GB201318394D0 (en) * | 2013-10-17 | 2013-12-04 | Univ Edinburgh | Composition |
| WO2023025672A1 (en) | 2021-08-25 | 2023-03-02 | Basf Se | Direct tableting auxiliary composition |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA01011287A (es) * | 1999-05-04 | 2003-07-14 | American Home Prod | Derivados de ciclotiocarbamato como moduladores de receptor de progesterona. |
| UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
| US6962908B2 (en) * | 2001-12-21 | 2005-11-08 | Warner Chilcott Company Inc. | Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| AR040644A1 (es) * | 2002-06-25 | 2005-04-13 | Wyeth Corp | Un moduladores del receptor de progesterona benzoxazina-2-tiona, una composicion farmaceutica, uso del compuesto para preparar un dedicamento para tratar una enfermedad neoplasica-hormona-dependiente y el uso de un compuesto benzoxazina-2-tiona, benzoxazina-2-ilideno cianamida o benzoxazina-2-iliden |
| BR0312024A (pt) | 2002-06-25 | 2005-03-22 | Wyeth Corp | Uso de derivados de ciclotiocarbamato no tratamento de condições relacionadas com hormÈnios |
| US8404272B2 (en) * | 2003-06-26 | 2013-03-26 | Poly-Med, Inc. | Fiber-reinforced composite rings for intravaginal controlled drug delivery |
| WO2005104711A2 (en) | 2004-04-27 | 2005-11-10 | Wyeth | Purification of progesterone receptor modulators |
| US7446211B2 (en) | 2004-04-27 | 2008-11-04 | Wyeth | Coupling process for generating reactive boron-containing derivatives of N-substituted pyrrole-2-carbonitriles to produce biaryls |
| ATE396189T1 (de) * | 2004-04-27 | 2008-06-15 | Wyeth Corp | Cyanopyrrolhaltige cyclische carbamat- und thiocarbamatbiaryle und verfahren zu deren herstellung |
| CN104208067A (zh) * | 2004-07-07 | 2014-12-17 | 惠氏公司 | 周期性黄体酮方案及试剂盒 |
| GT200500183A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| SI1778710T1 (sl) * | 2004-08-13 | 2012-05-31 | Wyeth Llc | Derivati tanaprogeta metaboliti in njihove uporabe |
| BRPI0514528A (pt) * | 2004-08-20 | 2008-06-10 | Wyeth Corp | estrutura de receptores de progesterona |
| MX2007013469A (es) | 2005-04-28 | 2008-01-22 | Wyeth Corp | Forma ii polimorfa de tanaproget. |
| DE602006007453D1 (de) * | 2005-04-28 | 2009-08-06 | Wyeth Corp | Zusammensetzungen mit mikronisiertem tanaproget |
| AR056328A1 (es) * | 2005-04-28 | 2007-10-03 | Wyeth Corp | TANAPROGET MICRONIZADO, COMPOSICIONES Y MÉTODOS PARA SU PREPARACIoN |
| US20060246128A1 (en) * | 2005-04-28 | 2006-11-02 | Wyeth | Micronized tanaproget and compositions containing same |
| EP1874743B1 (en) * | 2005-04-28 | 2013-07-17 | Wyeth LLC | Purified form of tanaproget |
| CN103989687A (zh) | 2005-06-09 | 2014-08-20 | 惠氏公司 | 含有炔雌醇的tanaproget组合物 |
-
2006
- 2006-04-26 AR ARP060101669A patent/AR056328A1/es not_active Application Discontinuation
- 2006-04-26 PL PL06751506T patent/PL1896034T3/pl unknown
- 2006-04-26 WO PCT/US2006/015837 patent/WO2006116514A2/en not_active Ceased
- 2006-04-26 BR BRPI0610437-1A patent/BRPI0610437A2/pt not_active IP Right Cessation
- 2006-04-26 DK DK06751506.4T patent/DK1896034T3/da active
- 2006-04-26 US US11/411,523 patent/US7767668B2/en not_active Expired - Fee Related
- 2006-04-26 EP EP06751506A patent/EP1896034B8/en not_active Not-in-force
- 2006-04-26 CN CN2006800142294A patent/CN101166532B/zh not_active Expired - Fee Related
- 2006-04-26 AU AU2006241113A patent/AU2006241113B2/en not_active Ceased
- 2006-04-26 TW TW095114814A patent/TW200716129A/zh unknown
- 2006-04-26 DE DE602006012972T patent/DE602006012972D1/de active Active
- 2006-04-26 SI SI200630649T patent/SI1896034T1/sl unknown
- 2006-04-26 ES ES06751506T patent/ES2340610T3/es active Active
- 2006-04-26 AT AT06751506T patent/ATE460937T1/de active
- 2006-04-26 CA CA2603806A patent/CA2603806C/en not_active Expired - Fee Related
- 2006-04-26 PT PT06751506T patent/PT1896034E/pt unknown
- 2006-04-26 JP JP2008509087A patent/JP5149159B2/ja not_active Expired - Fee Related
- 2006-04-26 MX MX2007013465A patent/MX2007013465A/es active IP Right Grant
-
2010
- 2010-04-01 US US12/752,520 patent/US8450312B2/en not_active Expired - Fee Related
- 2010-04-20 CY CY20101100356T patent/CY1110009T1/el unknown
-
2012
- 2012-07-31 JP JP2012169771A patent/JP2013006840A/ja active Pending
-
2013
- 2013-05-09 US US13/890,523 patent/US8772271B2/en not_active Expired - Fee Related
-
2014
- 2014-06-02 US US14/293,070 patent/US20140328925A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP5149159B2 (ja) | 2013-02-20 |
| MX2007013465A (es) | 2008-01-21 |
| PT1896034E (pt) | 2010-05-06 |
| EP1896034B1 (en) | 2010-03-17 |
| AU2006241113B2 (en) | 2011-08-18 |
| DK1896034T3 (da) | 2010-05-17 |
| AU2006241113A1 (en) | 2006-11-02 |
| WO2006116514A2 (en) | 2006-11-02 |
| US7767668B2 (en) | 2010-08-03 |
| DE602006012972D1 (de) | 2010-04-29 |
| CN101166532B (zh) | 2011-06-22 |
| TW200716129A (en) | 2007-05-01 |
| US20100189789A1 (en) | 2010-07-29 |
| US20130251807A1 (en) | 2013-09-26 |
| US20140328925A1 (en) | 2014-11-06 |
| SI1896034T1 (sl) | 2010-07-30 |
| JP2013006840A (ja) | 2013-01-10 |
| BRPI0610437A2 (pt) | 2012-10-23 |
| EP1896034B8 (en) | 2010-05-19 |
| ES2340610T3 (es) | 2010-06-07 |
| ATE460937T1 (de) | 2010-04-15 |
| AR056328A1 (es) | 2007-10-03 |
| JP2008539256A (ja) | 2008-11-13 |
| EP1896034A2 (en) | 2008-03-12 |
| CA2603806A1 (en) | 2006-11-02 |
| CY1110009T1 (el) | 2015-01-14 |
| WO2006116514A3 (en) | 2006-12-14 |
| CA2603806C (en) | 2013-03-19 |
| US8450312B2 (en) | 2013-05-28 |
| US20060246135A1 (en) | 2006-11-02 |
| CN101166532A (zh) | 2008-04-23 |
| US8772271B2 (en) | 2014-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1896034T1 (sl) | Mikronizirani sestavki tanaprogeta in postopki priprave le-tega | |
| IL181543A0 (en) | Dendrimer based compositions and methods of using the same | |
| IL189795A0 (en) | Isoindole-imide compounds and compositions comprising and methods of using the same | |
| ZA200808431B (en) | Fungicidal compositions and methods of using the same | |
| PL2335782T3 (pl) | Zastosowanie kompozycji zawierającej HFCO-1233zd | |
| IL184111A0 (en) | Prostaglandin-containing compositions and methods for enhancing the stability thereof | |
| ZA200710148B (en) | Methods of synthesizing substituted 3-cyanoquinolines and inermediates thereof | |
| IL186400A0 (en) | Compositions and methods for the inhibition of dishevelled proteins | |
| PL1951838T3 (pl) | Kompozycje zawierające fluoroolefiny i ich zastosowania | |
| IL190885A0 (en) | Immunogenic compositions and methods of use | |
| PL1940240T3 (pl) | Kompozycje izolatu białka i ich zastosowania | |
| IL189011A0 (en) | COMPOSITIONS OF tRNA AND USES THEREOF | |
| IL192098A (en) | Preparations and Methods for Manufacturing Preparations | |
| IL184834A0 (en) | Compositions and methods for the manufacture thereof | |
| PT1883665T (pt) | Composições polilactídeo e usos das mesmas | |
| IL191072A0 (en) | Therapeutic compositions and methods | |
| PL1891208T3 (pl) | Nowe, oparte na komórkach kompozycje oraz sposoby ich wytwarzania | |
| ZA200805711B (en) | Solid biocidal compositions and methods of using the same | |
| ZA200711068B (en) | Injectable compositions and process for preparation of such compositions | |
| PL2034973T5 (pl) | Kapsułkowane kompozycje nietrwałych związków i sposoby ich wytwarzania | |
| EP1893549A4 (en) | BIOZIDE CERAMIC COMPOSITIONS, PROCESSES AND MANUFACTURED ARTICLES | |
| GB0502479D0 (en) | Novel compositions | |
| GB0502475D0 (en) | Novel compositions | |
| IL186606A0 (en) | Compositions and uses of amooranin compounds | |
| EP1928252A4 (en) | PIGGY COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE |